HGH Fragment 176-191 | What is HGH Fragment 176-191

HGH Fragment 176-191 | What is HGH Fragment 176-191

HGH fragments refer to modified forms of amino acids, in this case amino acid 176-191, which is part of the peptide growth hormone in animals. Studies indicate that this chemical has potential use in improving the lipid profile while increasing muscle mass.
Research studies are focusing on the effects of administering HGH fragment 176-191 to subjects that have HIV-associated lipodystrophy as a means of controlling excess abdominal fat which stems from such conditions. This chemical appears to have potential for such a purpose because it does not have an impact on glycemic control.

Effects of Amino Acid Sequence with Insulin

• Human growth hormone or hgh has frequently been studied for its insulin potentiating effects.

• Three systems have been studied to better understand these effects. These include how insulin binds to certain hepatic plasma membrane receptors or isolated hepatocytes, insulin intolerance tests at the intravenous level and the modulation of insulin-dependent glycogen phosphorylase or glycogen synthase in adipose or muscle tissue.

• Results of this monitoring establish that hexapeptide allows for the minimum active sequence. This strongly indicates that insulin potentiating actions in active peptides is designed to bind insulin to specific receptors.

• This system allows the body of the subject to modulate the actions of the phosphorylase and glycogen synthase to produce hypoglycemia. This increases the storage of glycogen within the adipose tissue, liver and muscles for further use as an animal’s body requires.

Hyperglycemic Action in Synthetic C-Terminal Fragments

• Various synthetic peptides are designed to correspond with amino acids, including 176-191 within the body to create necessary reactions.

• Studies have noted the reactions of these peptides and the presence of human growth hormone or hgh and the in vivo effects they had on rats with normal health and size.

• Four such peptides including hgh fragment 176-191 were able to increase blood glucose levels for a short period of time. They were also able to achieve a longer lasting raise in the insulin levels in the plasma.

• The remaining peptides, hgh 180-191 and 179-191 were found to be inert in the systems that were tested. Single injections of peptides which contained 178-191 and the hgh molecule would reduce the animal’s sensitivity to insulin in the intravenous insulin tolerance tests by a significant level.

• These findings help to show how various amino acids work together to better manage insulin travel and use throughout the body of the subject, helping to achieve a balance. The findings also indicate that peptides which are biologically active, require a minimum of the appropriate informational sequence to be present in order to remain functional.

• This sequence must also have the proper physical configuration in order to elicit the desired response from the organism. These findings help researchers better understand how to administer synthetic 176-191 in an organic setting.

• Ongoing research into the appropriate solution of hgh fragment 176-191 solutions is ongoing. This will assist in determining the appropriate chemical solution to better match the natural form of this amino acid which would be present in an organic setting, allowing synthetic versions to behave much like these natural chemicals when introduced into an organic environment.

More Peptide Info...

Great info on HGH Fragment 176-191

Great info on HGH Fragment 176-191

What is Human Growth Hormone (HGH) Fragment 176-191?

The HGH Fragment is a modified form of amino acids 176-191 at the C-terminal region of the human growth hormone (HGH). Studies have shown that it works by mimicking the way natural HGH regulates fat metabolism but without the adverse effects on insulin sensitivity (blood sugar) or cell proliferation (muscle growth) that is seen with unmodified HGH. Like unmodified GH, the HGH fragment 176-191 stimulates lipolysis (breaking down of fat) and inhibits lipogenesis (the formation of fatty acids and other lipids in the body).

HGH fragment 176-191 is meant to be 12.5 times stronger than human growth hormone (HGH) for weight loss than standard human growth hormone (HGH).

Of particular note is that in studies HGH fragment 176-191 had the ability to increase IGF-1 levels which translates into the fragments ability to give anti-aging effects.

How much Human Growth Hormone (HGH) Fragment 176-191 should be used?
In most studies favorable results have been shown with dosages between 500-1000mcg or 5-10mcg/kg split into multiple dosages per day.

How long should Human Growth Hormone (HGH) Fragment 176-191 be used?
In most studies no adverse side effects were reported with continuous use per the dosage limits in the above answer.

What is a typical protocol for Human Growth Hormone (HGH) Fragment 176-191?
Studies have suggested the following:
A typical conservation protocol would be:
250mcg in the morning plus
250mcg pre lunch plus
250mcg in the evening (pre-bed).
Approximately 5-7 days a week - subcutaneous injections

A more aggressive protocol would be:
350mcg in the morning plus
350mcg 30 minutes prior to training
350mcg in the evening (pre-bed).
Approximately 5-7 days a week - subcutaneous injections

When dosing multiple times a day at least 3 hours should separate the administrations.
Should food be consumed before or after the injection of Human Growth Hormone (HGH) Fragment 176-191?
Studies have shown that administration should ideally be done on either an empty stomach or with only protein in the stomach. Fats and carbohydrates blunt growth hormone release. After administering the peptides wait about 20 minutes (no more than 30 but no less than 15 minutes) to eat. At that point the growth hormone pulse has reached its peak and you can eat what you want.<

More Peptide Info...

HGH Fragment 176-191 Dosage Instructions

HGH Fragment 176-191 Dosage Instructions

HGH Fragment 176-191 Dose per injection: 250mcg (0.25mg)
Injections per vial: 8 x 250mcg injections
Amount to Inject: If you have used 1ml of water for mixing then a 250mcg dosage = 0.125ml (or 12.5 units on Insulin Syringe). If you have used 2ml of water for mixing then 250mcg = 0.25ml (or 25 units). If you have used 3ml of water for mixing then 250mcg = 0.375ml (or 37.5 units).

Injection Frequency

1 x 250mcg per day, taken either prior to exercise (cardio) or at night time before bed. For those whose budget allows it, the dosage can be increased to 1 x 500mcg injection per day of 2 x 250mcg injections per day.

Diet Restrictions

Since HGH Fragment 176-191 works by releasing stored fat into the blood for usage as energy, it therefore makes sense to not consume calories around the time of your injection, since the body will more than likely preferably use them over the fat released by the peptide. Your results will be much more significant if you follow the following principles:

Morning injection: Inject first thing in the morning, do some cardio exercise, then wait several hours before eating breakfast. When you do eat your first meal try to make it high in protein, low fat and low carbohydrates.

Night time injection: Have your last meal of the day at least 3 hours before going to bed and try to make it a meal high in protein, low in fat and low in carbohydrates (a good example would be some kind of meat or fish along with salad/vegetables).
Following either one of the above routines will ensure your body best utilizes the fat burning effects of HGH Fragment 176-191 as you will either be burning fat all morning, particularly during your cardio exercise, or you will be experiencing significant fat loss all night while you sleep.

Recommended Diet

For fat loss to occur with any kind of weight loss supplement, a calorie deficit needs to be present. This means that each day you are eating less calories than the energy your body is expending (so your body then has to burn stored fat for energy). For women this is about 1500-2000 calories and for males this is about 2500-3000 calories, depending on the level of activity (those who exercise would obviously be closer to the higher value).

Furthermore, to obtain the best results possible and most amount of fat loss from HGH Fragment 176-191 you should be following a diet which is high in protein, moderate in fat and low in carbohydrates, in addition to performing cardio exercise as often as possible. Developing these kind of habits will not only allow you to lose fat while using the product, but also keep it off afterwards.
(All info gathered via internet )

More Peptide Info...

HGH fragment 176-191

HGH fragment 176-191

* Reduces the most stubborn abdominal fat.
* Increases muscle mass.
* Increases IGF-1 levels, in an effective manner, thus making this a peptide that burns fat and exhibits anabolic function.
* Increases energy expenditure.
* Improves lipid profiles and lipolytic activity.
* Does not negatively impact blood glucose level, nor does cell proliferation occur, like Human Growth Hormone.
* Extremely potent and effective fat burner.




The (HGH fragment 176-191) is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. To date studies suggest that (HGH fragment 176-191) has several beneficial features: it reduces abdominal fat (in particular visceral fat), without compromising glycemic control (blood glucose), it increases muscle mass and improves the lipid profile. These characteristics make it an ideal candidate for the treatment of excess abdominal fat, an important aspect of HIV-associated lipodystrophy.
At a dosage of 500mcg the (HGH fragment 176-191) was shown to increase lipolytic activity in adipose tissue. In other words this fragment potently burns body fat, especially stubborn adipose body fat, and it does so potently! Of significance, is that the fragment has no negative impact on insulin sensitivity, a stark contrast from its Human Growth Hormone counterpart.(Ng FM, Sun J,Sharma L, Libinaka R, Jiang WJ, and Gianello R 2000).
Not only does the (HGH fragment 176-191) not interfere with the body~~~8217;s natural insulin regulation as Human Growth Hormone can, the (HGH fragment 176-191) does not result in cellular proliferation as Human Growth Hormone does. The fragment is similar to Human Growth Hormone, hence the shared amino acid sequence, however, the (HGH fragment 176-191) does not induce hyperglycaemia or reduce insulin secretion. The (HGH fragment 176-191) does not compete for the hGH receptor and nor does it induce cell proliferation, unlike Human Growth Hormone. (Wu Z, Ng FM. 1993). Thusly, this is a very beneficial peptide in terms of burning fat, without unwanted and undesirable side effects. Of particular note is the fragments ability to increase IGF-1 levels which translate into the fragments ability to give collateral anti-aging and anabolic effects along with its ability to induce lipplytic (fat burning) activity.
In yet another study, the (HGH fragment 176-191) exhibits the ability to burn through adipose tissue by increasing lipolytic activity (the breakdown of fat) , in the most stubborn body fat (adipose tissue) while increasing energy expenditure and glucose and fat oxidation in ob/ob mice treated with (HGH fragment 176-191). In addition, (HGH fragment 176-191) increased in vitro lipolytic activity and decreased lipogenic activity in isolated adipose tissue from obese rodents and humans.(Heffernan MA, Jiang WJ, Thorburn AW, Ng FM. 2000).
Thusly, the (HGH fragment 176-191) exhibits the ability to burn through stubborn adipose tissue, while increasing energy expenditure, muscle mass, and fat oxidation. All studies have pointed to the fact that the fragment is an effective treatment for obesity and fat loss, and much safer than its Human Growth Hormone counterpart.

Includes Sodium Chloride for Dilution, all vials are dosed at 2mg (2000mcg).



-The mean Relative Insulin Resistance (RIR) increased in all groups with no statistically significant differences among groups (Figure 2).
-There were no statistically significant treatment differences in the changes from the baseline in fasting insulin levels and OGTT insulin (data not shown).


-At week 12, a statistically significant treatment difference (p=0.04, ANOVA) in mean total cholesterol was observed.
-Values increased by 5% and 3% in the placebo and 1 mg groups, respectively and decreased by 6% in the 2mg group (Figure 5).
-Changes were significantly different in the 2mg group when compared to the placebo and 1mg groups (p<0.05), and were mainly explained by comparable changes in the mean non-HDL cholesterol values (Figure 5.).
-HDL cholesterol and triglycerides levels remained unchanged (data not shown).

-Mean IGF-1 levels increased in a dose dependant manner over the study period (Figure 6).
-IGF-1 increases were associated with no clear dose-related pattern of adverse events suspected to be related to the study drug.
.

RESEARCH DOSAGE: frag 176-191

500mcg-2mg every day
STORAGE:
REFRGIRATE UPON RECEIPT.
KEEP REFRIGERATED AFTER RECONSTITUTION ALLOW 24 HOURS FOR THE PEPTIDE TO SETTLE BEFORE BEGINNING YOUR RESEARCH.
NCLUDES SODIUM CHLORIDE FOR DILUTION Academic References & Further Information
Heffernan MA, Jiang WJ, Thorburn AW, Ng FM. (2000). Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism. Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E501-7.
Ng FM, Sun J,Sharma L, Libinaka R, Jiang WJ, and Gianello R (2000). Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000;53(6):274-8.
Wu Z, Ng FM (1993). Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone. Biochem Mol Biol Int. 1993 May;30(1):187-96.

More Peptide Info...